DAL is trading at $69.68 (-3.6%) amid modest market weakness and pre-earnings caution ahead of tomorrow's Q4 report.
- Analysts anticipate Q4 EPS of $1.55 (a 16% decline) on revenue of $15.42B.
- Wolfe Research raised its price target today to $83 from $70, maintaining an Outperform rating.